
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
Chelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2716-2732
Open Access | Times Cited: 27
Chelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2716-2732
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomas
Tian Gao, Xinyu He, Junyi Wang, et al.
Cell Reports Medicine (2025), pp. 101990-101990
Open Access | Times Cited: 1
Tian Gao, Xinyu He, Junyi Wang, et al.
Cell Reports Medicine (2025), pp. 101990-101990
Open Access | Times Cited: 1
The future of precision cancer therapy might be to try everything
Elie Dolgin
Nature (2024) Vol. 626, Iss. 7999, pp. 470-473
Open Access | Times Cited: 7
Elie Dolgin
Nature (2024) Vol. 626, Iss. 7999, pp. 470-473
Open Access | Times Cited: 7
Therapeutically targeting the unique disease landscape of pediatric high-grade gliomas
Dasun Fernando, Afsar U. Ahmed, Bryan Williams
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Dasun Fernando, Afsar U. Ahmed, Bryan Williams
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Poly-pharmacology of existing drugs: How to crack the code?
Baptiste Mouysset, Marion Le Grand, Luc Camoin, et al.
Cancer Letters (2024) Vol. 588, pp. 216800-216800
Open Access | Times Cited: 5
Baptiste Mouysset, Marion Le Grand, Luc Camoin, et al.
Cancer Letters (2024) Vol. 588, pp. 216800-216800
Open Access | Times Cited: 5
Pädiatrische Onkologie: Fortschritte in Diagnostik und Therapie
Hedwig E. Deubzer, Anne Thorwarth, S Castelli, et al.
Deleted Journal (2025)
Closed Access
Hedwig E. Deubzer, Anne Thorwarth, S Castelli, et al.
Deleted Journal (2025)
Closed Access
Whatever It Takes: Parents' Perspectives of Patient-Derived Xenograft Mouse Models for Poor Prognosis Childhood Cancer
Eden G. Robertson, Kate Hetherington, Jacqueline Hunter, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Eden G. Robertson, Kate Hetherington, Jacqueline Hunter, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
A novel TRKB-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activation
Lauren M. Brown, Gábor Tax, Pablo Acera Mateos, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Lauren M. Brown, Gábor Tax, Pablo Acera Mateos, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Progress in Biomimetic Microdevices for Anticancer Drug Screening and their Potential for Enhancing In Vivo Efficacy
Ching‐Te Kuo, Yen‐Tzu Liao, Hsinyu Lee
Advanced NanoBiomed Research (2025)
Open Access
Ching‐Te Kuo, Yen‐Tzu Liao, Hsinyu Lee
Advanced NanoBiomed Research (2025)
Open Access
Functional precision medicine for pediatric cancers
M. Emmy M. Dolman, Paul G. Ekert
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 940-941
Closed Access | Times Cited: 3
M. Emmy M. Dolman, Paul G. Ekert
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 940-941
Closed Access | Times Cited: 3
Tumor organoids in cancer medicine: from model systems to natural compound screening
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
Rong Cong, Can Lu, Xinying Li, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 89-109
Open Access
Ex Vivo Drug Screening: An Emerging Paradigm in the Treatment of Childhood Cancer
Anees Ahmed, Emily R. Cox, Lindsay Lane, et al.
Journal of Pediatric Hematology/Oncology (2025)
Closed Access
Anees Ahmed, Emily R. Cox, Lindsay Lane, et al.
Journal of Pediatric Hematology/Oncology (2025)
Closed Access
A novel TRKB-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activation
Lauren M. Brown, Gábor Tax, Pablo Acera Mateos, et al.
Research Square (Research Square) (2025)
Closed Access
Lauren M. Brown, Gábor Tax, Pablo Acera Mateos, et al.
Research Square (Research Square) (2025)
Closed Access
High throughput screening aids clinical decision‐making in refractory acute myeloid leukaemia
Sophie Jessop, N. Fuentos‐Bolanos, Chelsea Mayoh, et al.
Cancer Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 2
Sophie Jessop, N. Fuentos‐Bolanos, Chelsea Mayoh, et al.
Cancer Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 2
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma
Jourdin R.C. Rouaen, Antonietta Salerno, Tyler Shai-Hee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Jourdin R.C. Rouaen, Antonietta Salerno, Tyler Shai-Hee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART
Birgit Geoerger, Francisco Bautista, Nicolás André, et al.
European Journal of Cancer (2024) Vol. 208, pp. 114201-114201
Closed Access | Times Cited: 1
Birgit Geoerger, Francisco Bautista, Nicolás André, et al.
European Journal of Cancer (2024) Vol. 208, pp. 114201-114201
Closed Access | Times Cited: 1
Emerging and Biological Concepts in Pediatric High-Grade Gliomas
Abigail Yoel, Shazia Adjumain, Yuqing Liang, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1492-1492
Open Access | Times Cited: 1
Abigail Yoel, Shazia Adjumain, Yuqing Liang, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1492-1492
Open Access | Times Cited: 1
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia
Cara E. Toscan, Hannah McCalmont, Amir Ashoorzadeh, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Cara E. Toscan, Hannah McCalmont, Amir Ashoorzadeh, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Advanced High Throughput Screening Platforms in Drug Discovery
Chinmayi Joshi, Drashti Makwana
Advances in medical technologies and clinical practice book series (2024), pp. 35-74
Closed Access | Times Cited: 1
Chinmayi Joshi, Drashti Makwana
Advances in medical technologies and clinical practice book series (2024), pp. 35-74
Closed Access | Times Cited: 1
Bridging the Gap: From Petri Dish to Patient - Advancements in Translational Drug Discovery
Mohamed El‐Tanani, Syed Arman Rabbani, Yahia El‐Tanani, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41317-e41317
Open Access | Times Cited: 1
Mohamed El‐Tanani, Syed Arman Rabbani, Yahia El‐Tanani, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41317-e41317
Open Access | Times Cited: 1
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases
Sebastian Jeising, Ann‐Christin Nickel, Johanna Trübel, et al.
Journal of Neuro-Oncology (2024) Vol. 169, Iss. 3, pp. 613-623
Open Access
Sebastian Jeising, Ann‐Christin Nickel, Johanna Trübel, et al.
Journal of Neuro-Oncology (2024) Vol. 169, Iss. 3, pp. 613-623
Open Access
Investigation of nanostructured lipid carriers for fast intracellular localization screening using the Echo liquid handler
Christina Glader, Ramona Jeitler, Stefanie Stanzer, et al.
International Journal of Pharmaceutics (2024), pp. 124698-124698
Open Access
Christina Glader, Ramona Jeitler, Stefanie Stanzer, et al.
International Journal of Pharmaceutics (2024), pp. 124698-124698
Open Access
Whole-Process 3D ECM-Encapsulated Organoid-Based Automated High-Throughput Screening Platform Accelerates Drug Discovery for Rare Diseases
Zhaoting Xu, Hui Yang, Yuru Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Zhaoting Xu, Hui Yang, Yuru Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Working with Miraculous Mice: Mus musculus as a Model Organism
Anick Standley, Jinhan Xie, Angelica W.Y. Lau, et al.
Current Protocols (2024) Vol. 4, Iss. 10
Open Access
Anick Standley, Jinhan Xie, Angelica W.Y. Lau, et al.
Current Protocols (2024) Vol. 4, Iss. 10
Open Access
Molecular and modular intricacies of precision oncology
Ravneet Chhabra
Frontiers in Immunology (2024) Vol. 15
Open Access
Ravneet Chhabra
Frontiers in Immunology (2024) Vol. 15
Open Access
Emerging Technologies for the Assessment of Natural Killer Cell Activity
Anna Luise Grab, Alexander Nesterov‐Mueller
J — Multidisciplinary Scientific Journal (2024) Vol. 7, Iss. 4, pp. 457-471
Open Access
Anna Luise Grab, Alexander Nesterov‐Mueller
J — Multidisciplinary Scientific Journal (2024) Vol. 7, Iss. 4, pp. 457-471
Open Access